PH284 increased feelings of hunger and was safe in patients with cancer cachexia, which results in significant weight loss.

FFECTOR Therapeutics (NASDAQ:EFTR – Get Free Report) will likely be posting its quarterly earnings results on Tuesday, January 21st. Analysts expect eFFECTOR Therapeutics to post earnings of ($2.02) ...

Research analysts at Zacks Small Cap upped their FY2024 EPS estimates for Evaxion Biotech A/S in a research note issued to investors on Wednesday, January 15th. Zacks Small Cap analyst B. Sorensen now ...